Budecort
Budecort

35.02
A clinical formulation indicated for Asthma & Breathing. This solution suppresses inflammatory responses in the bronchial passages to maintain open airways and facilitate easier respiratory function.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Budesonide
Reference Brand
Budesonide
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Inhalation Aerosol
Regulatory Classification
Rx
Primary Category
Respiratory Health
Product Category
Corticosteroid
Pharmacological Class
Glucocorticoid
Manufacturer Description
An inhaled steroid designed to manage chronic asthma symptoms and formulated to alleviate airway inflammation to support improved breathing.
Mechanism of Action
It reduces inflammation and swelling in the lungs by suppressing immune cells and chemicals. This makes airways less sensitive to asthma triggers.
Route of Administration
Inhalation
Onset Time
1–2 weeks for full effect
Duration
12–24 hours
Contraindications
Status asthmaticus, Acute asthma attack relief, Hypersensitivity to budesonide
Severe Adverse Events
Adrenal suppression, Reduced bone density, Glaucoma, Paradoxical bronchospasm
Common Side Effects
Throat irritation, Dry mouth, Hoarseness
Uncommon Side Effects
Oral thrush, Headache, Upper respiratory infection, Cough
Drug Interactions
Ketoconazole, Itraconazole, Ritonavir, Clarithromycin
Pregnancy Safety Warnings
Generally considered the preferred inhaled steroid in pregnancy.
Age Restrictions
Approved for children 6 years and older (inhaler).
Storage Guidelines
Store at room temperature. Keep canister away from heat.
Related Products
Fluticasone, Beclomethasone
Information for Budecort is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories